The URL address of official journal web site is http://e-jar.org
Aims & Scope statement: https://www.e-jar.org/content/about/aims_and_scope.html
The Journal of Acupuncture Research (JAR), founded in 1983, is the official international journal of the Korean Acupuncture & Moxibustion Medicine Society. The journal, by providing a platform for dissemination and discussion, aims to strengthen the scientific understanding of the safety and effectiveness (efficacy) of acupuncture and related therapies in integrative medicine as well as in traditional medicine.
There is a long history of research on acupuncture. Work that takes into account historical empirical evidence, incorporating a broad evidence-based approach to acupuncture, and that is of interest and relevance to those involved in the practice, research, and education of acupuncture-based therapies in health care would be welcome.JAR considers to publish editorials, original articles, review articles, short communications, case reports, and letters to the editor on:
Readership:JAR is primarily for Korean Medicine doctors and integrative medicine researchers from around the world. Its readership can be expanded to other positions:
This is an Open Access journal distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc-nd/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The content from JAR in part or in whole may be used, reproduced, disseminated, or displayed for non-commercial purposes. Customary bibliographic citations, including author and publisher attribution, date, article title, JAR must be indicated as reference. If an original work is subsequently reproduced or disseminated not in its entirety (i.e., only in part or as a derivative work), this must be clearly indicated. Archiving the manuscript or the publicated article of JAR on another archiving organization is not available without permission of the editorial office of JAR (email@example.com).
The permission MUST be obtained from the editorial office of JAR (firstname.lastname@example.org) prior to any commercial use of material from the open access version of the journal:
JAR adheres to the guidelines and best practices published by professional organizations, including ICMJE Recommendations and the Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by the Committee on Publication Ethics, COPE; the Directory of Open Access Journals, DOAJ; the World Association of Medical Editors, WAME; and Open Access Scholarly Publishers Association, OASPA; https://doaj.org/bestpractice). Furthermore, all processes of handling research and publication misconduct shall follow the applicable COPE flowchart (https://publicationethics.org/resources/flowcharts).
All authors must meet the authorship criteria of ‘Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals’ listed on https://www.icmje.org/. Qualifying for authorship is required for all authors and the order of authorship is to be decided between the coauthors. The authorship credit should be based on substantial contributions to: (1) substantial contributions to the conception or designing of the work; or the acquisition, analysis, or interpretation of data for the work; (2) drafting or revising of the work critically for important intellectual content; (3) final approval of the version to be published; and (4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Any persons who do not meet the 4 criteria above should be placed as contributors in Acknowledgments section.
One author should be chosen to act as a corresponding author. The corresponding author does not have to be the first author. The corresponding author will be responsible for the entire communications to/from the Editorial Office, editors and etc. In case of multicenter studies, a corporate author directly responsible for the manuscript should be appointed.
Correction of authorship: Any requests for such changes in authorship (adding author(s), removing author(s), or rearranging the order of authors) after the initial manuscript submission and before publication should be explained in writing to the editor in a letter or email from all authors. This letter must be signed by all authors of the paper. A copyright assignment must be completed by every author.
When the Journal faces suspected cases of research and publication misconduct such as a redundant (duplicate) publication, falsification of data, plagiarism, improprieties of authorship, undisclosed conflicts of interest, misappropriation of the ideas of others, violation of generally accepted research practices, material failure to comply with legislative and regulatory requirements affection research, inappropriate behavior in relation to misconduct, the resolving process will follow the flowchart provided by the Committee on Publication Ethics (https://publicationethics.org/resources/flowcharts). The Editorial Board will discuss the suspected cases and reach a decision. We will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed.
|Element||Example 1||Example 2||Example 3||Example 4|
|Will individual participant data be available (including data dictionaries)?||Yes||Yes||Yes||Yes|
|What data in particular will be shared?||All individual participant data collected during the trial, after deidentification.||Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).||Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).||Not available|
|What other documents will be available?||Study protocol, statistical analysis plan, informed consent form, clinical study report, analytic code||Study protocol, statistical analysis plan, analytic code||Study protocol||Not available|
|When will data be available (start and end dates)?||Immediately following publication. No end date.||Beginning at 3 months and ending at 5 years following the article publication.||Beginning at 9 months and ending at 36 months following the article publication.||Not applicable|
|With whom?||Anyone who wishes to access the data.||Researchers who provide a methodologically sound proposal.||Investigators whose proposed use of the data has been approved by an independent review committee (“learned intermediary”) identified for this purpose.||Not applicable|
|For what types of analyses?||Any purpose||To achieve aims in the approved proposal.||For individual participant data meta-analysis.||Not applicable|
|By what mechanism will data be made available?||Data are available indefinitely at (link to be included).||Proposals should be directed to xxx@yyy. To gain access, data requestors will need to sign a data access agreement.||Proposals may be submitted up to 36 months following article publication. After 36 months the data will be available in our University's data warehouse but without investigator support other than deposited metadata.||Not applicable|
|Data are available for 5 years at a third-party website (link to be included).||Information regarding submitting proposals and accessing data may be found at (link to be provided).|
JAR operates a double blind review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor’s decision is final. All submitted manuscripts are screened for duplication through Crosscheck (https://app.ithenticate.com) before review.
The Editorial Office of Journal of Acupuncture Research receives and reviews all submitted manuscripts, and all submitted manuscripts are considered confidential. The submitted manuscripts are initially screened for the format. Once the manuscript is provisionally accepted, it is sent to the three most relevant referees for review. The referees are selected by the editor from the Editorial Board's database or the board members' recommendation. The referees are then requested to evaluate based on originality, validity, presentation, and importance and interest, and, when considered necessary, statistics.
Acceptance of a manuscript depends on the evaluation, critiques, and recommended decision made by the referees. A referee may recommend 'accept', 'minor revision', 'major revision' and 'reject'. Upon opposing recommended decisions between referees, or author and referee(s), the Editor-in-Chief has the full right to decide whether the manuscript will be published in the journal. Three repeated decisions of 'major revisions' are regarded as a 'reject' and rejected papers will not be considered further.
The reviewed manuscripts with comments, recommended directions, and revisions are returned to the corresponding author. The corresponding author is to submit the revised manuscript accompanied by point-to-point replies to the comments given by the editor and how the revisions have been made. There should be a reasonable explanation for any noncompliance with the recommendations. In cases where references, tables, or figures are moved, added or deleted during the revision process, renumbering must be done so that all references, tables, and figures are cited in numeric order. If the revised paper is not received within 2 months of decision, the manuscript is considered to have been withdrawn.
When the final decision on the acceptance of the manuscript is made, the Editorial Office notifies the corresponding author. The peer-review process takes approximately 8-12 weeks.
Any appeal against an editorial decision must be made within 2 weeks of the date of the decision letter. Authors who wish to appeal against a decision should contact the editor-in-chief, explaining in detail the reasons for the appeal. All appeals will be discussed with at least one other associate editor. If consensus cannot be reached thereby, an appeal will be discussed at a full editorial meeting. The process of handling complaints and appeals follows the guidelines of COPE available from (https://publicationethics.org/appeals). Journal of Acupuncture Research does not consider second appeals.
https://www.e-jar.org/content/about/open_access.htmlJournal of Acupuncture Research is an open access journal. Articles are distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derives License (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Author(s) do not need to be permitted for use of tables or figures published in JAR in other journals, books, or media for scholarly and educational purposes. This is in accordance with the Budapest Open Access Initiative definition of open access.
The journal is owned by the Korean Acupuncture & Moxibustion Medicine Society(http://www.kamms.org)
The management team is as follows:
Ho-Sueb Song Gil Korean Medical Hospital, Gachon University, Korea
Editors for the Review
Gi Young Yang Pusan National University School of Korean Medicine, Korea
Eun jung Kim College of Oriental Medicine, Dongguk University, Korea
Byung-Kwan Seo Kyung Hee University Hospital at Gangdong, Korea
Myeong Soo Lee Korea Institute of Oriental Medicine, Korea
Sang-Hoon Lee Kyung Hee University Korean Medicine Hospital, Korea
Aejin Song College of Korean Medicine, Gachon University, Korea
Seung-Deok Lee Dongguk University Los Angeles, USA
Jihye Hwang Gil Korean Medical Hospital, Gachon University, Korea
Sujin LeeMEDrang Inc., Korea
Beom Mun MEDrang Inc., Korea
Website and JATS XML Producer
Goun Bae INFOrang Inc., Korea
The Editorial team is available from Editorial Board page at the front part of the journal.
Editor-in-Chief : Ho-Sueb Song Gil Korean Medical Hospital, Gachon University, Korea
E-mail : email@example.com
Editorial OfficeAejin Song
Yeonhak Kim, Yoona Oh, Jihun Kim, Eunseok Kim, Gi Young Yang, Byung Ryul Lee*Journal of Acupuncture Research 2022;39: 317-322
Min-Gi Jo, Jun-Yeong Jang, Min-Jung Ko, Sang-Yeup Chae, Seungeun Lee, Dongmin Lee, Won Suk Sung, Jung-Hyun Kim, Bonhyuk Goo, Yeon-Cheol Park, Yong-Hyeon Baek, Sang-Soo Nam, Byung-Kwan Seo*Journal of Acupuncture Research 2022;39: 258-266
Study selection and exclusion flow chart.|@|~(^,^)~|@|
Classification of the number of studies. (A) According to the number of treatment points; (B) According to the treatment frequency and (C) According to the number of treatment period.